JAKARTA (Yosefardi) – Pharmaceutical company PT Daria-Varia Laboratoria Tbk (DVLA) posted net profit of Rp77.85 billion in first nine months of 2014, declined 17.9% from Rp95.1 billion in the same period of 2013.
Net sales declined 3.4% to Rp819.57 billion from previous Rp847.93 billion. Its assets totaled Rp1.25 trillion while liability amounted Rp296.5 billion.
Meanwhile state pharmaceutical company PT Indofarma Tbk (INAF) suffered loss of Rp35.67 billion in the period, narrowed from Rp61.17 billion a year earlier. Its assets reached Rp1.3 trillion while liability amounted Rp760 billion.